Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by raptor57on Oct 11, 2018 9:03am
249 Views
Post# 28779522

Finally there may be reckoning of dodgy financials.......

Finally there may be reckoning of dodgy financials.......This lends well I am sure to APH's full finacials....Raptor

 

Globe says Canopy, rivals hear disclosures inadequate

 

2018-10-11 08:33 ET - In the News

See In the News (C-WEED) Canopy Growth Corp

The Globe and Mail reports in its Thursday, Oct. 11, edition that in the first comprehensive regulatory review of the cannabis industry's accounting and disclosures, Canada's securities enforcers say they see widespread disclosure problems that are getting in the way of investors' understanding of how to best invest in marijuana stocks. The Globe's David Milstead writes that regulators reviewed the filings of 70 publicly listed weed companies, identified multiple issues and offered guidance in a Canadian Securities Administrators staff notice on Wednesday. While the directives do not have the force of new regulations, companies that ignore the new guidance risk extended conversations with regulators and the prospect of refiling their financial statements. The pot companies were responsive to regulators' concerns, the CSA said. "Where deficient disclosure was identified during our review, issuers either committed to prospective improvements or, when the deficiencies were pervasive, refiled certain documents." Many had inadequate information in either their financial statements, or in the text of the management analysis that is supposed to help explain the company's financial performance.

© 2018 Canjex Publishing Ltd. All rights reserved.


Bullboard Posts